Company: CORT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001628280-25-019942
Chunk: 20

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 20
---
 ISVP, or other investment advisory clients. Information regarding the holdings of Ingalls and ISVP is based on information obtained from Amendment No. 16 to Schedule 13G filed by Ingalls on February 21, 2025 with respect to its holdings as of December 31, 2024. ISVP is an investment partnership managed under an investment advisory contract by Ingalls, a registered broker dealer and a registered investment advisor. Ingalls holds investment authority but not voting authority over shares held by its investment advisory clients. Mr. Thomas O. Boucher, Jr., a Managing Director of Ingalls, and Mr. Robert L. Gipson and Adam Janovic, Senior Directors of Ingalls, are the general partners of ISVP and share investment and voting power over the shares held by ISVP. Each of these individuals disclaims beneficial ownership of all such shares, except to the extent of his individual pecuniary interest therein. The address for Ingalls is 1 Rockefeller Plaza, New York, NY 10020. |

<div align='center'>12</div>

| (6)  |     | Information regarding the holdings of Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation, or Renaissance Technologies, is based on information obtained from Amendment No. 4 to Schedule 13G filed by Renaissance Technologies on February 13, 2024 with respect to its holdings as of December 31, 2023. The address for Renaissance Technologies is 800 Third Avenue, New York, New York 10022.                          |
| (7)  |     | Includes (a) 2,981,985 shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust and (b) 3,946,873 shares that may be acquired by Dr. Belanoff within 60 days of April 17, 2025 pursuant to options.                                                                                                                                                                                                                        |
| (8)  |     | Includes (a) 955,262 shares held in The Baker Revocable Trust of which Mr. Baker is a trustee, (b) 1,046,631 shares held by a Roth IRA for the benefit of Mr. Baker, (c) 3,308,303 shares held by Saunders Holdings, L.P. of which Mr. Baker is a trustee of a trust which is the general partner and (d) 240,000 shares that may be acquired by Mr. Baker within 60 days of April 17, 2025 pursuant to options